BioScrip (NASDAQ: BIOS) reported Q1 EPS of ($0.26), may not compare to the analyst estimate of ($0.04). Revenue for the quarter came in at $261.7 million versus the consensus estimate of $259.6 million.

For earnings history and earnings-related data on BioScrip (BIOS) click here.